A9600 Sr89 strontium
Also known as: Metastron, Sr-89, strontium therapy
Strontium Sr-89 chloride injection used therapeutically for treatment of metastatic bone pain in oncology patients.
In Plain Language
radioactive bone pain treatment; cancer pain therapy
Clinical Context
Used in targeted radiotherapy for palliative treatment of osteoblastic metastases and bone pain in advanced cancer patients.
RVU Information
CPT A9600 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
HCPCS A-codes cover medical supplies, equipment, and transport services. Documentation must establish medical necessity and include a physician order. For durable medical equipment (DME), a Certificate of Medical Necessity (CMN) or detailed written order may be required.
Specialties
Frequently Asked Questions
What is CPT code A9600?
CPT A9600 (Sr89 strontium) is a A Codes code. Strontium Sr-89 chloride injection used therapeutically for treatment of metastatic bone pain in oncology patients.
Does Medicare cover A9600?
Medicare coverage for A9600 depends on medical necessity and applicable Local Coverage Determinations (LCDs). Used in targeted radiotherapy for palliative treatment of osteoblastic metastases and bone pain in advanced cancer patients. A physician order is typically required.
When is CPT A9600 used?
Used in targeted radiotherapy for palliative treatment of osteoblastic metastases and bone pain in advanced cancer patients.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.